MARKET

ENVB

ENVB

Enveric Biosciences Inc
NASDAQ
1.530
-0.130
-7.83%
After Hours: 1.700 +0.17 +11.11% 19:59 06/12 EDT
OPEN
1.650
PREV CLOSE
1.660
HIGH
1.690
LOW
1.500
VOLUME
1.81M
TURNOVER
--
52 WEEK HIGH
17.64
52 WEEK LOW
1.500
MARKET CAP
5.63M
P/E (TTM)
-0.0516
1D
5D
1M
3M
1Y
5Y
1D
Enveric Biosciences Expands At-The-Market Equity Offering
TipRanks · 4d ago
Enveric Biosciences files prospectus supplement to offer additional $2.43 million in shares via ATM agreement
PUBT · 4d ago
Enveric Biosciences to attend UBS Virtual CNS Day
PUBT · 4d ago
Enveric Biosciences Releases Updated Investor Presentation Materials
TipRanks · 4d ago
Weekly Report: what happened at ENVB last week (0601-0605)?
Weekly Report · 5d ago
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
TipRanks · 06/04 15:00
Enveric Biosciences Initiates Investigational New Drug-enabling Genotoxicity Studies Of EB-003
Benzinga · 06/02 12:10
Enveric Biosciences starts IND-enabling genotoxicity studies for lead neuroplastogen EB-003
PUBT · 06/02 12:03
More
About ENVB
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The Company is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.

Webull offers Enveric Biosciences Inc stock information, including NASDAQ: ENVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENVB stock methods without spending real money on the virtual paper trading platform.